Molina Healthcare, Inc. (MOH)
 NYSE: MOH · Real-Time Price · USD
 152.49
 +1.39 (0.92%)
  Oct 31, 2025, 11:48 AM EDT - Market open
Molina Healthcare Market Cap
Molina Healthcare has a market cap or net worth of $7.84 billion as of October 31, 2025. Its market cap has decreased by -58.58% in one year.
Market Cap 
 7.84B
Enterprise Value 
 7.44B
1-Year Change 
 -58.58%
Ranking 
 Category 
 Stock Price 
$152.49
Market Cap Chart
Since July 2, 2003, Molina Healthcare's market cap has increased from $496.00M to $7.84B, an increase of 1,480.24%. That is a compound annual growth rate of 13.15%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 7.77B | -53.35% | 
| Dec 31, 2024 | 16.65B | -20.97% | 
| Dec 29, 2023 | 21.06B | 9.23% | 
| Dec 30, 2022 | 19.28B | 3.82% | 
| Dec 31, 2021 | 18.58B | 47.29% | 
| Dec 31, 2020 | 12.61B | 48.24% | 
| Dec 31, 2019 | 8.51B | 17.34% | 
| Dec 31, 2018 | 7.25B | 65.62% | 
| Dec 29, 2017 | 4.38B | 42.00% | 
| Dec 30, 2016 | 3.08B | -8.57% | 
| Dec 31, 2015 | 3.37B | 30.17% | 
| Dec 31, 2014 | 2.59B | 62.92% | 
| Dec 31, 2013 | 1.59B | 26.16% | 
| Dec 31, 2012 | 1.26B | 23.53% | 
| Dec 30, 2011 | 1.02B | 21.16% | 
| Dec 31, 2010 | 842.20M | 44.14% | 
| Dec 31, 2009 | 584.30M | 23.22% | 
| Dec 31, 2008 | 474.20M | -56.80% | 
| Dec 31, 2007 | 1.10B | 20.27% | 
| Dec 29, 2006 | 912.60M | 23.37% | 
| Dec 30, 2005 | 739.70M | -42.04% | 
| Dec 31, 2004 | 1.28B | 100.19% | 
| Dec 31, 2003 | 637.50M | 28.53% | 
| Jul 2, 2003 | 496.00M | - | 
View and export this data all the way back to 2003. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 758.14B | 
| Johnson & Johnson | 455.48B | 
| AbbVie | 403.13B | 
| UnitedHealth Group | 312.23B | 
| AstraZeneca | 255.76B | 
| Novartis AG | 236.67B | 
| Novo Nordisk | 222.08B | 
| Abbott Laboratories | 216.98B |